1. Home
  2. EVR vs NBIX Comparison

EVR vs NBIX Comparison

Compare EVR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evercore Inc.

EVR

Evercore Inc.

HOLD

Current Price

$259.32

Market Cap

13.7B

Sector

Finance

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$138.20

Market Cap

15.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVR
NBIX
Founded
1995
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
15.5B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
EVR
NBIX
Price
$259.32
$138.20
Analyst Decision
Buy
Strong Buy
Analyst Count
8
22
Target Price
★ $359.38
$180.91
AVG Volume (30 Days)
418.0K
★ 971.6K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
★ 1.04%
N/A
EPS Growth
★ 54.74
41.95
EPS
★ 9.56
3.30
Revenue
★ $3,880,084,000.00
$161,626,000.00
Revenue This Year
$22.69
$24.73
Revenue Next Year
$13.31
$13.14
P/E Ratio
★ $27.06
$41.45
Revenue Growth
29.49
★ 977.51
52 Week Low
$254.31
$122.14
52 Week High
$388.71
$186.12

Technical Indicators

Market Signals
Indicator
EVR
NBIX
Relative Strength Index (RSI) 32.08 27.09
Support Level N/A $125.85
Resistance Level $354.84 $138.74
Average True Range (ATR) 8.21 3.94
MACD -0.04 -1.08
Stochastic Oscillator 12.28 2.02

Price Performance

Historical Comparison
EVR
NBIX

About EVR Evercore Inc.

Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. Evercore operates globally, with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: